Skip to results
Modify your search
NARROW
1-20 of 33
Authors: Catherine Godfrey
Journal Article
ACCEPTED MANUSCRIPT
Virology Outcomes of Tenofovir-Lamivudine-Dolutegravir in Treatment-Naïve and Virologically Suppressed Individuals Switching From an Nnrti-Based Regimen: An Observational Analysis at 13 Sites Open Access
Open Forum Infectious Diseases, ofaf270, https://doi.org/10.1093/ofid/ofaf270
Published: 02 May 2025
Journal Article
Use of an Ethinyl Estradiol/Etonogestrel Vaginal Ring Alters Vaginal Microbial Communities in Women With HIV Get access
The Journal of Infectious Diseases, Volume 231, Issue 3, 15 March 2025, Pages 583–594, https://doi.org/10.1093/infdis/jiae524
Published: 31 October 2024
Journal Article
Effectiveness of Double-Dose Dolutegravir in People Receiving Rifampin-based Tuberculosis Treatment: An Observational, Cohort Study of People With HIV From 6 Countries Free
Clinical Infectious Diseases, Volume 80, Issue 1, 15 January 2025, Pages 137–143, https://doi.org/10.1093/cid/ciae269
Published: 13 May 2024
Journal Article
2068. Progress in the Infection Prevention and Control Monitoring System for the United States President’s Emergency Plan for AIDS Relief (PEPFAR) Programs and Supported Facilities Open Access
Open Forum Infectious Diseases, Volume 10, Issue Supplement_2, December 2023, ofad500.138, https://doi.org/10.1093/ofid/ofad500.138
Published: 27 November 2023
Journal Article
A Randomized Clinical Trial of Human Papillomavirus Test-and-Treat as Compared to Cytology-Based Screening for Prevention of Cervical Cancer Among Women With Human Immunodeficiency Virus: AIDS Clinical Trials Group Protocol A5282 Free
Clinical Infectious Diseases, Volume 75, Issue 8, 15 October 2022, Pages 1280–1288, https://doi.org/10.1093/cid/ciac213
Published: 16 March 2022
Journal Article
Reply to Bottanelli et al Free
The Journal of Infectious Diseases, Volume 225, Issue 11, 1 June 2022, Pages 2051–2052, https://doi.org/10.1093/infdis/jiac071
Published: 26 February 2022
Journal Article
Impact of Tamoxifen on Vorinostat-Induced Human Immunodeficiency Virus Expression in Women on Antiretroviral Therapy: AIDS Clinical Trials Group A5366, The MOXIE Trial Free
Clinical Infectious Diseases, Volume 75, Issue 8, 15 October 2022, Pages 1389–1396, https://doi.org/10.1093/cid/ciac136
Published: 17 February 2022
Journal Article
Monitoring Emerging Human Immunodeficiency Virus Drug Resistance in Sub-Saharan Africa in the Era of Dolutegravir Free
The Journal of Infectious Diseases, Volume 225, Issue 3, 1 February 2022, Pages 364–366, https://doi.org/10.1093/infdis/jiab382
Published: 20 July 2021
Journal Article
The Association Between Weight Gain, Sex, and Immune Activation Following the Initiation of Antiretroviral Therapy Free
The Journal of Infectious Diseases, Volume 224, Issue 10, 15 November 2021, Pages 1765–1774, https://doi.org/10.1093/infdis/jiab210
Published: 19 April 2021
Journal Article
A Phase 1/2 Randomized, Placebo-Controlled Trial of Romidespin in Persons With HIV-1 on Suppressive Antiretroviral Therapy Free
The Journal of Infectious Diseases, Volume 224, Issue 4, 15 August 2021, Pages 648–656, https://doi.org/10.1093/infdis/jiaa777
Published: 21 December 2020
Journal Article
Association of Male Sex and Obesity With Residual Plasma Human Immunodeficiency Virus 1 Viremia in Persons on Long-Term Antiretroviral Therapy Free
The Journal of Infectious Diseases, Volume 223, Issue 3, 1 February 2021, Pages 462–470, https://doi.org/10.1093/infdis/jiaa373
Published: 30 June 2020
Journal Article
Risk Factors for Weight Gain Following Switch to Integrase Inhibitor–Based Antiretroviral Therapy Free
Clinical Infectious Diseases, Volume 71, Issue 9, 1 November 2020, Pages e471–e477, https://doi.org/10.1093/cid/ciaa177
Published: 26 February 2020
Journal Article
Diverse Human Immunodeficiency Virus–1 Drug Resistance Profiles at Screening for ACTG A5288: A Study of People Experiencing Virologic Failure on Second-line Antiretroviral Therapy in Resource-limited Settings Free
Clinical Infectious Diseases, Volume 71, Issue 7, 1 October 2020, Pages e170–e177, https://doi.org/10.1093/cid/ciz1116
Published: 14 November 2019
Journal Article
Pharmacokinetics and Pharmacodynamics of Depot Medroxyprogesterone Acetate in African Women Receiving Treatment for Human Immunodeficiency Virus and Tuberculosis: Potential Concern for Standard Dosing Frequency Free
Clinical Infectious Diseases, Volume 71, Issue 3, 1 August 2020, Pages 517–524, https://doi.org/10.1093/cid/ciz863
Published: 05 September 2019
Journal Article
Obesity and Fat Metabolism in Human Immunodeficiency Virus–Infected Individuals: Immunopathogenic Mechanisms and Clinical Implications Free
The Journal of Infectious Diseases, Volume 220, Issue 3, 1 August 2019, Pages 420–431, https://doi.org/10.1093/infdis/jiz118
Published: 20 March 2019
Journal Article
Dolutegravir plus lamivudine for initial treatment of HIV-1-infected participants with HIV-1 RNA <500 000 copies/mL: week 48 outcomes from ACTG 5353 Free
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 5, May 2019, Pages 1376–1380, https://doi.org/10.1093/jac/dky564
Published: 18 January 2019
Journal Article
Reply to Suthar et al Free
The Journal of Infectious Diseases, Volume 219, Issue 4, 15 February 2019, Pages 673–674, https://doi.org/10.1093/infdis/jiy558
Published: 11 October 2018
Journal Article
A Randomized, Placebo-Controlled Trial of the Quadrivalent Human Papillomavirus Vaccine in Human Immunodeficiency Virus-Infected Adults Aged 27 Years or Older: AIDS Clinical Trials Group Protocol A5298 Free
Clinical Infectious Diseases, Volume 67, Issue 9, 1 November 2018, Pages 1339–1346, https://doi.org/10.1093/cid/ciy274
Published: 05 April 2018
Journal Article
As-Needed Vs Immediate Etoposide Chemotherapy in Combination With Antiretroviral Therapy for Mild-to-Moderate AIDS-Associated Kaposi Sarcoma in Resource-Limited Settings: A5264/AMC-067 Randomized Clinical Trial Free
Clinical Infectious Diseases, Volume 67, Issue 2, 15 July 2018, Pages 251–260, https://doi.org/10.1093/cid/ciy044
Published: 22 January 2018
Journal Article
ACTG A5353: A Pilot Study of Dolutegravir Plus Lamivudine for Initial Treatment of Human Immunodeficiency Virus-1 (HIV-1)–infected Participants With HIV-1 RNA <500000 Copies/mL Free
Clinical Infectious Diseases, Volume 66, Issue 11, 1 June 2018, Pages 1689–1697, https://doi.org/10.1093/cid/cix1083
Published: 14 December 2017
